You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

KANTREX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Kantrex, and when can generic versions of Kantrex launch?

Kantrex is a drug marketed by Apothecon and is included in six NDAs.

The generic ingredient in KANTREX is kanamycin sulfate. There are five drug master file entries for this compound. Additional details are available on the kanamycin sulfate profile page.

Summary for KANTREX
Drug patent expirations by year for KANTREX
Recent Clinical Trials for KANTREX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
McMaster UniversityN/A
Rede TBPhase 3
Institute of Tropical Medicine, BelgiumPhase 3

See all KANTREX clinical trials

US Patents and Regulatory Information for KANTREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon KANTREX kanamycin sulfate CAPSULE;ORAL 060516-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061655-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061655-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 062564-002 Sep 21, 1984 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon KANTREX kanamycin sulfate INJECTABLE;INJECTION 061901-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon KANTREX kanamycin sulfate CAPSULE;ORAL 061911-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.